Monotherapy still useful in a bunch of patients with arterial hypertension

Abstract

The maintenance of an adequate blood pressure (BP) control during the life-time in the general population still constitutes the most relevant challenge in the prevention of cardiovascular disease and new goals are considered in clinical practice [1,2]. This must be accompanied by the adequate management of the associated risk factors and comorbidities that so frequently accompany the elevation in BP. It is well established that the joint effect of genetic component and inadequate life-style underlie the progressive increase in BP.